SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $5,610,000 | +40.0% | 374,472 | +13.8% | 0.01% | +42.9% |
| Q1 2016 | $4,006,000 | -11.7% | 329,203 | +15.4% | 0.01% | -12.5% |
| Q4 2015 | $4,537,000 | +32.7% | 285,150 | +27.8% | 0.01% | +14.3% |
| Q3 2015 | $3,420,000 | -34.0% | 223,110 | +4.7% | 0.01% | -30.0% |
| Q2 2015 | $5,178,000 | +7.9% | 213,010 | +3.2% | 0.01% | +11.1% |
| Q1 2015 | $4,798,000 | +18.3% | 206,345 | +27.7% | 0.01% | +12.5% |
| Q4 2014 | $4,056,000 | -11.7% | 161,545 | +9.4% | 0.01% | -11.1% |
| Q3 2014 | $4,594,000 | +50.4% | 147,719 | +25.1% | 0.01% | +50.0% |
| Q2 2014 | $3,055,000 | +374.4% | 118,119 | +328.4% | 0.01% | +500.0% |
| Q1 2014 | $644,000 | +0.2% | 27,571 | +8.8% | 0.00% | 0.0% |
| Q4 2013 | $643,000 | +36.8% | 25,331 | +9.9% | 0.00% | 0.0% |
| Q3 2013 | $470,000 | +2.2% | 23,051 | +5.1% | 0.00% | 0.0% |
| Q2 2013 | $460,000 | – | 21,942 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Timpani Capital Management LLC | 110,215 | $2,248,000 | 1.32% |
| Healthcare Value Capital, LLC | 73,822 | $1,506,000 | 1.32% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,014,863 | $20,703,000 | 0.96% |
| Perimeter Capital Partners, LLC | 248,893 | $5,077,000 | 0.94% |
| Tekla Capital Management LLC | 270,031 | $5,509,000 | 0.61% |
| SECTORAL ASSET MANAGEMENT INC | 564,325 | $11,512,000 | 0.55% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 168,268 | $3,432,000 | 0.35% |
| MENTA CAPITAL LLC | 30,480 | $622,000 | 0.32% |
| KOPP INVESTMENT ADVISORS LLC | 39,934 | $815,000 | 0.30% |
| Broadfin Capital, LLC | 68,300 | $1,393,000 | 0.25% |